Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[The present status of, and problems with the development of FLT3 kinase inhibitors].

[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Apr 2006

Kiyoi Hitoshi

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Quinazolines
Share to Chaperonins
Share to fms-Like Tyrosine Kinase 3
Share to Leukemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Promyelocytic, Acute

Share to Piperazines

Share to Protein Kinase C

Share to Staurosporine

Source

Identifiers

PMID: 16715961

Genes

FLT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[The present status of, and problems with the development of FLT3 kinase inhibitors].PMID 16715961Read ↗

[Ⅱ. Recent Advances and Problems of FLT3 Inhibitor in AML Treatment].Semantic proximity Read ↗

[Possibility of targeting FLT3 kinase for the treatment of leukemia].Semantic proximity Read ↗

[FLT3 kinase inhibitors for the treatment of acute leukemia].Semantic proximity Read ↗

[Advancesin FLT3 inhibitors for acute myeloid leukemia].Semantic proximity Read ↗

Strategies targeting FLT3 beyond the kinase inhibitors.Semantic proximity Read ↗

FLT3 signaling and the development of inhibitors that target FLT3 kinase activity.Semantic proximity Read ↗

[New therapeutic option for leukemia patients, with FLT3/Aurora kinase inhibitor, KW-2449: strategy and comparison with other kinase inhibitors].Semantic proximity Read ↗

FLT3 tyrosine kinase inhibitors.Semantic proximity Read ↗

[EGFR pathway and mechanism of action of tyrosine kinase inhibitors].Semantic proximity Read ↗

[Mutations of the gene coding for the receptor tyrosine kinase FLT3 in acute myeloid leukemia. Significance as the disease-specific molecular marker for diagnosis, prognosis and innovative therapy approaches].Semantic proximity Read ↗

Investigational drugs targeting FLT3 for leukemia.Semantic proximity Read ↗

FLT3 inhibitors: a story of the old and the new.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.